Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis

被引:0
|
作者
Chen, I-Wen [1 ]
Yu, Ting-Sian [2 ]
Lin, Chien-Hung [3 ]
Hung, Kuo-Chuan [3 ]
机构
[1] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan
[2] I Shou Univ, E Da Hosp, Dept Anesthesiol, Kaohsiung, Taiwan
[3] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan
关键词
D O I
10.1002/jmv.29718
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis
    Ombelet, Sien
    Castanares-Zapatero, Diego
    Desimpel, Fabian
    Hulstaert, Frank
    Stordeur, Sabine
    Roberfroid, Dominique
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [2] Nirmatrelvir-ritonavir for COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E218 - E218
  • [3] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
    Cheng, Franco Wing Tak
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Wong, Carlos King Ho
    Li, Xue
    Zhang, Irene Ran
    Tang, Sydney Chi Wai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (05): : 1244 - 1253
  • [4] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
    Focosi, Daniele
    Nicastri, Emanuele
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
  • [5] Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19
    Zhang, Huan
    Tan, Xiaojiao
    Chen, Junjun
    Zhang, Zheng
    Wang, Chenxi
    Shi, Haiqing
    Li, Yao
    Li, Jianbo
    Kang, Yan
    Jin, Xiaodong
    Liao, Xuelian
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [6] Nirmatrelvir-ritonavir (Paxlovid®), a treatment for Covid-19
    Buxeraud, Jacques
    Faure, Sebastien
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2020, 61 (617): : 10 - 12
  • [7] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 Response
    Wan, Eric Yuk Fai
    Yan, Vincent Ka Chun
    Mok, Anna Hoi Ying
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : eL230265
  • [8] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
  • [9] Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Cheema, Huzaifa A. A.
    Jafar, Uzair
    Sohail, Aruba
    Shahid, Abia
    Sahra, Syeda
    Ehsan, Muhammad
    Athar, Farwa
    Shah, Jaffer F.
    Sah, Ranjit
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [10] Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19
    Yang, Hui
    Yu, Xin
    Hou, Wenjing
    Liu, Xiangduan
    Chen, Jiaojiao
    Zhang, Ying
    Wang, Ying
    Zhu, Ying
    Qian, Qing
    Ma, Kuifen
    An, Zhuoling
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (03)